Τo help protect people everywhere, the European Commission presented a European strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19.
The EU-funded consortium Exscalate4CoV has announced that an already registered generic drug used to treat osteoporosis, Raloxifene, could be an effective treatment for COVID-19 patients with mildly symptomatic infection.
The Commission launched an EU-wide open public consultation to ensure that its forthcoming new Digital Education Action Plan will reflect the EU's education and training experience during the Coronavirus crisis.
The European Union Agency for Fundamental Rights (FRA) moderated a webinar on 19 June on universities and human rights cities. The Global Campus of Human Rights invited representatives from over 20 universities to take part.
The European Commission has published an updated version of the Horizon 2020 Work Programme (the “Work Programme”). The new updates, which were published on the 17th of June 2020, officially align the Work Programme with the pledge of the European Commission, during the Coronavirus Global Response initiative on 4 May, to invest €1 billion from the Horizon 2020 programme into coronavirus research and innovation.